AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 115 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $376,000 | +53.5% | 40,001 | +24.5% | 0.00% | – |
| Q2 2020 | $245,000 | -0.8% | 32,136 | -19.3% | 0.00% | – |
| Q1 2020 | $247,000 | -80.6% | 39,840 | -62.0% | 0.00% | -100.0% |
| Q4 2019 | $1,275,000 | +9.5% | 104,718 | +3.9% | 0.00% | 0.0% |
| Q3 2019 | $1,164,000 | -52.3% | 100,803 | -58.7% | 0.00% | 0.0% |
| Q2 2019 | $2,440,000 | +197.2% | 244,139 | +283.1% | 0.00% | – |
| Q1 2019 | $821,000 | -45.4% | 63,735 | -35.6% | 0.00% | -100.0% |
| Q4 2018 | $1,504,000 | +12.7% | 98,992 | +48.3% | 0.00% | 0.0% |
| Q3 2018 | $1,335,000 | +37.3% | 66,759 | +34.1% | 0.00% | 0.0% |
| Q2 2018 | $972,000 | -47.7% | 49,774 | -46.0% | 0.00% | 0.0% |
| Q1 2018 | $1,857,000 | +72.3% | 92,216 | +13.4% | 0.00% | – |
| Q4 2017 | $1,078,000 | -65.8% | 81,312 | -52.3% | 0.00% | -100.0% |
| Q3 2017 | $3,149,000 | +32.9% | 170,632 | +32.5% | 0.00% | +50.0% |
| Q2 2017 | $2,369,000 | +381.5% | 128,763 | +489.0% | 0.00% | – |
| Q1 2017 | $492,000 | -64.4% | 21,860 | -44.9% | 0.00% | -100.0% |
| Q4 2016 | $1,381,000 | +4.1% | 39,649 | -26.7% | 0.00% | +100.0% |
| Q3 2016 | $1,326,000 | -14.2% | 54,106 | -16.2% | 0.00% | 0.0% |
| Q2 2016 | $1,545,000 | +57.2% | 64,559 | +50.9% | 0.00% | 0.0% |
| Q1 2016 | $983,000 | +1113.6% | 42,779 | +1482.6% | 0.00% | – |
| Q4 2015 | $81,000 | -50.6% | 2,703 | -35.7% | 0.00% | – |
| Q3 2015 | $164,000 | -85.6% | 4,206 | -74.6% | 0.00% | – |
| Q2 2015 | $1,140,000 | +29.5% | 16,533 | +1.4% | 0.00% | -100.0% |
| Q1 2015 | $880,000 | +21.7% | 16,302 | -5.4% | 0.00% | – |
| Q4 2014 | $723,000 | -87.5% | 17,231 | -90.8% | 0.00% | -100.0% |
| Q3 2014 | $5,777,000 | +99.4% | 186,380 | +28.7% | 0.01% | +100.0% |
| Q2 2014 | $2,897,000 | +62.5% | 144,834 | +54.4% | 0.00% | +50.0% |
| Q1 2014 | $1,783,000 | +796.0% | 93,806 | +1035.1% | 0.00% | – |
| Q4 2013 | $199,000 | -23.8% | 8,264 | -33.6% | 0.00% | – |
| Q3 2013 | $261,000 | -35.4% | 12,441 | -31.5% | 0.00% | – |
| Q2 2013 | $404,000 | – | 18,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |